[Antipsychotic neuroplegic and neuroleptic agents. III. Phenothiazines (2nd part)].
D000818:Animals; D001519:Behavior / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology* / Q000627:therapeutic use; D004064:Digestive System / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects; D010640:Phenothiazines / Q000494:pharmacology / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy*; D012119:Respiration / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects
D010640:Phenothiazines; D002746:Chlorpromazine
Neuroplégiques et neuroleptiques antipsychotiques. III. Phénothiazines (2ème partie).